IL159349A0 - One dose vaccination with mycoplasma hyopneumoniae - Google Patents

One dose vaccination with mycoplasma hyopneumoniae

Info

Publication number
IL159349A0
IL159349A0 IL15934902A IL15934902A IL159349A0 IL 159349 A0 IL159349 A0 IL 159349A0 IL 15934902 A IL15934902 A IL 15934902A IL 15934902 A IL15934902 A IL 15934902A IL 159349 A0 IL159349 A0 IL 159349A0
Authority
IL
Israel
Prior art keywords
mycoplasma hyopneumoniae
dose vaccination
vaccination
dose
hyopneumoniae
Prior art date
Application number
IL15934902A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23168589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL159349(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL159349A0 publication Critical patent/IL159349A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15934902A 2001-07-02 2002-06-07 One dose vaccination with mycoplasma hyopneumoniae IL159349A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30263601P 2001-07-02 2001-07-02
PCT/IB2002/002121 WO2003003941A2 (en) 2001-07-02 2002-06-07 One dose vaccination with mycoplasma hyopneumoniae

Publications (1)

Publication Number Publication Date
IL159349A0 true IL159349A0 (en) 2004-06-01

Family

ID=23168589

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15934902A IL159349A0 (en) 2001-07-02 2002-06-07 One dose vaccination with mycoplasma hyopneumoniae

Country Status (42)

Country Link
US (3) US6846477B2 (xx)
EP (3) EP1474067B2 (xx)
JP (1) JP2005515162A (xx)
KR (1) KR20040030785A (xx)
CN (3) CN101524532B (xx)
AP (1) AP2003002937A0 (xx)
AR (1) AR034678A1 (xx)
AT (1) ATE412426T2 (xx)
AU (1) AU2002309109B2 (xx)
BG (1) BG66481B1 (xx)
BR (1) BR0210804A (xx)
CA (1) CA2451626C (xx)
CY (1) CY1108749T1 (xx)
CZ (1) CZ305781B6 (xx)
DE (1) DE60229666D1 (xx)
DK (3) DK2842569T3 (xx)
DO (1) DOP2002000431A (xx)
EA (1) EA009901B1 (xx)
ES (3) ES2312580T5 (xx)
GT (1) GT200200138A (xx)
HK (4) HK1068250A1 (xx)
HR (1) HRP20031079A2 (xx)
HU (1) HU230246B1 (xx)
IL (1) IL159349A0 (xx)
IS (1) IS7076A (xx)
MA (1) MA27047A1 (xx)
MX (1) MXPA03011599A (xx)
NO (1) NO342654B1 (xx)
NZ (1) NZ530106A (xx)
OA (1) OA12638A (xx)
PA (1) PA8549701A1 (xx)
PE (1) PE20030285A1 (xx)
PL (1) PL209773B1 (xx)
PT (3) PT1474067E (xx)
SK (1) SK288010B6 (xx)
TN (1) TNSN03155A1 (xx)
TW (1) TWI329514B (xx)
UA (1) UA78707C2 (xx)
UY (1) UY27366A1 (xx)
WO (1) WO2003003941A2 (xx)
YU (1) YU102203A (xx)
ZA (1) ZA200309698B (xx)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
WO2006056841A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Multiple-strain mycoplasma hyopneumoniae vaccines
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
EP3868400A1 (en) 2005-12-29 2021-08-25 Boehringer Ingelheim Animal Health USA Inc. Multivalent pcv2 immunogenic compositions and methods of producing such compositions
PT2371383E (pt) 2005-12-29 2015-11-24 Boehringer Ingelheim Vetmed Utilização de uma composição imunogénica de pcv2 para atenuar os sintomas clínicos em porcos
EP1991262A4 (en) * 2006-03-03 2009-11-04 Merial Ltd MYCOPLASMA HYOPNEUMONIAE VACCINE
WO2008064299A2 (en) * 2006-11-22 2008-05-29 Boehringer Ingelheim Vetmedica, Inc. Methods of reducing porcine circovirus-associated disease outbreaks
EP2101815A4 (en) * 2006-12-11 2010-10-06 Boehringer Ingelheim Vetmed EFFICIENT PROCESS FOR THE TREATMENT OF PORCINE CIRCOVIRUS AND LAWSONIA INTRACELLULARIS INFECTIONS
US8865183B2 (en) 2006-12-15 2014-10-21 Boehringer Ingelheim Vetmedica, Inc. Treatment of pigs with PCV2 antigent
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
RU2489164C9 (ru) * 2007-11-06 2014-01-20 ВАЙЕТ ЭлЭлСи АВИРУЛЕНТНАЯ АДЪЮВАНТНАЯ ЖИВАЯ ВАКЦИНА ПРОТИВ Mycoplasma hyopneumoniae
BRPI0821456A2 (pt) * 2007-12-31 2015-06-16 Boehring Ingelheim Vetmedica Inc Partícula similar à pcv2 orf2 com inserção de aminoácido estranho
CN101236206B (zh) * 2008-01-17 2014-10-15 中国兽医药品监察所 一种猪肺炎支原体重组抗原elisa检测试剂盒
EP2242511A4 (en) 2008-01-23 2012-10-24 Boehringer Ingelheim Vetmed IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
ES2728949T3 (es) * 2008-06-27 2019-10-29 Zoetis Services Llc Composiciones adyuvantes novedosas
TWI583403B (zh) 2009-06-04 2017-05-21 國立感染症研究所 黴漿菌感染症用疫苗
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
DK2569007T3 (en) 2010-05-11 2016-01-25 Intervet Int Bv VACCINE AGAINST Mycoplasma hyopneumoniae SUITABLE FOR ADMINISTRATION IN PRESENCE OF maternally derived antibodies
RU2722357C2 (ru) * 2010-07-26 2020-05-29 Кью Байолоджикс Инк. Иммуногенные противовоспалительные композиции
US8546149B2 (en) 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
BR112013004594B1 (pt) * 2010-08-27 2020-07-28 Intervet International B. V. método para a determinação de um conteúdo de antígeno
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
UA115053C2 (uk) 2012-03-07 2017-09-11 Сева Санте Анімаль Композиція, що містить антиген і ліпополісахарид у формі масло-в-воді, та спосіб її використання (варіанти)
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
CN104968365B (zh) 2012-12-28 2018-04-03 勃林格殷格翰动物保健有限公司 支原体疫苗的制备方法
KR102355614B1 (ko) 2012-12-28 2022-01-27 베링거잉겔하임베트메디카게엠베하 마이코플라스마 항원을 포함하는 면역원성 조성물
ES2812552T3 (es) * 2013-02-05 2021-03-17 Agricultural Tech Res Inst Vacuna subunitaria contra Mycoplasma spp.
CN104338125A (zh) * 2013-07-29 2015-02-11 普莱柯生物工程股份有限公司 一种猪肺炎支原体抗原在预防和治疗猪呼吸道疾病综合征方面的应用
AU2014321369B2 (en) 2013-09-19 2020-04-16 Zoetis Services Llc Oil-based adjuvants
KR20220083861A (ko) 2013-10-02 2022-06-20 베링거 인겔하임 애니멀 헬스 유에스에이 인크. Ｐｃｖ2 ｏｒｆ2 단백질 변이체 및 이로 이루어진 바이러스 유사 입자
ES2714000T3 (es) * 2013-11-21 2019-05-24 Agricultural Tech Res Inst Composición para prevenir y curar una infección por micoplasma
CN105012948B (zh) * 2014-04-18 2019-07-30 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
CN104248753B (zh) * 2014-05-15 2017-07-28 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
BR102014014727B1 (pt) * 2014-06-16 2018-04-03 Ouro Fino Saúde Animal Ltda COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, GENE SINTÉTICO CODIFICANTE DO COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, COMPOSIÇÃO ANTIGÊNICA, PROCESSO DE OBTENÇÃO DE UM COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae
US9814769B2 (en) 2014-09-30 2017-11-14 Qatar University Vaccines against pathogenic Escherichia coli and methods of using the same
WO2016115456A1 (en) 2015-01-16 2016-07-21 Zoetis Services Llc Foot-and-mouth disease vaccine
KR20160099223A (ko) * 2015-02-12 2016-08-22 강원대학교산학협력단 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
US10519199B2 (en) * 2016-08-12 2019-12-31 Innovac Vaccine composition comprising recombinant protein for preventing swine Mycoplasma infection
RU2668799C1 (ru) * 2017-09-08 2018-10-02 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp.
CN108101969A (zh) * 2017-11-13 2018-06-01 南京大爻网络科技有限公司 一种与猪支原体肺炎相关的抗原及其应用
RU2695679C1 (ru) * 2018-09-11 2019-07-25 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp.
RU2759427C2 (ru) * 2019-07-08 2021-11-12 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp
CN117305192A (zh) * 2023-12-01 2023-12-29 北京瑞阳瑞泰生物科技有限公司 一种猪肺炎支原体rt02株、疫苗组合物及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0283840A3 (en) * 1987-03-26 1989-08-09 Ml Technology Ventures, L.P. Mycoplasma hyopneumoniae antigen and uses therefor
US5252328A (en) 1987-03-26 1993-10-12 Martin Marietta Energy Systems, Inc. Mycoplasma hyopneumoniae antigen and uses therefor
DE3881993T2 (de) 1987-09-18 1993-09-30 Akzo Nv Mycoplasma-Impfstoff.
AU7682091A (en) 1990-04-02 1991-10-30 Synergen, Inc. Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals
CA2082155C (en) 1990-05-29 2008-04-15 Krishnaswamy I. Dayalu Swine pneumonia vaccine and method of preparation
US6113916A (en) * 1990-05-29 2000-09-05 American Cyanamid Company Method of enhancing cell mediated immune responses
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP0475185A1 (en) 1990-08-27 1992-03-18 Nippon Flour Mills Co., Ltd. DNA's encoding surface antigen of mycoplasma hyopneumoniae, DNA fragments for primer, recombinant antigenic peptides and diagnostic method of mycoplasmal pneumoniae of swine using same
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
DK0839050T3 (da) 1992-09-28 2004-10-25 Wyeth Corp Fremgangsmåde til at forstærke celleformidlede immunreaktioner
US5530874A (en) 1993-02-02 1996-06-25 3Com Corporation Network adapter with an indication signal mask and an interrupt signal mask
WO1995009870A1 (en) 1993-10-07 1995-04-13 Iowa State University Research Foundation, Inc. Characterization of mycoplasma hyopneumoniae adhesins
ZA953703B (en) 1994-05-10 1996-01-10 American Home Prod Modified live BRSV vaccine
US5788962A (en) 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
AUPN178995A0 (en) 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition
ES2224273T3 (es) 1996-09-30 2005-03-01 University Of Arkansas Metodo para producir inmunidad activa por medio de un conjugado de vacuna.
EP0846468B1 (en) 1996-12-05 2004-06-09 Akzo Nobel N.V. Non-virulent mycoplasma synoviae and vaccine thereof
BR9815321A (pt) 1997-11-26 2002-01-02 Univ Iowa State Res Found Inc Vacina de mycoplasma hyopneumoniae recombinante
AU6128900A (en) * 1999-09-29 2001-04-05 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs

Also Published As

Publication number Publication date
US20030109473A1 (en) 2003-06-12
CZ20033466A3 (cs) 2005-06-15
HK1180224A1 (zh) 2013-10-18
UA78707C2 (en) 2007-04-25
CN102872456A (zh) 2013-01-16
SK288010B6 (sk) 2012-10-02
TWI329514B (en) 2010-09-01
PT2842569T (pt) 2019-06-17
MXPA03011599A (es) 2005-03-07
ES2312580T3 (es) 2009-03-01
DK2842569T3 (da) 2019-05-20
CN1551781A (zh) 2004-12-01
CN101524532A (zh) 2009-09-09
EP2027873B8 (en) 2015-11-11
EP1474067B2 (en) 2017-08-16
EP2842569B1 (en) 2019-04-10
HRP20031079A2 (en) 2005-10-31
BG66481B1 (bg) 2015-02-27
UY27366A1 (es) 2003-04-30
OA12638A (en) 2006-06-15
EP1474067B1 (en) 2008-10-29
PE20030285A1 (es) 2003-03-27
TNSN03155A1 (fr) 2005-12-23
PT1474067E (pt) 2008-11-14
GT200200138A (es) 2003-05-15
EP2027873A1 (en) 2009-02-25
MA27047A1 (fr) 2004-12-20
NO342654B1 (no) 2018-06-25
BR0210804A (pt) 2005-05-03
DK1474067T4 (en) 2017-10-16
DE60229666D1 (de) 2008-12-11
WO2003003941A2 (en) 2003-01-16
CY1108749T1 (el) 2014-04-09
CN101524532B (zh) 2014-03-19
CN102872456B (zh) 2016-01-20
ES2729579T3 (es) 2019-11-04
PL373367A1 (en) 2005-08-22
BG108546A (bg) 2005-02-28
EP2027873B1 (en) 2015-09-09
SK15792003A3 (sk) 2005-09-08
CZ305781B6 (cs) 2016-03-16
PA8549701A1 (es) 2003-01-24
ES2312580T5 (es) 2017-12-11
KR20040030785A (ko) 2004-04-09
EA009901B1 (ru) 2008-04-28
US20050013823A1 (en) 2005-01-20
US6846477B2 (en) 2005-01-25
EP1474067A4 (en) 2005-08-10
ES2550458T3 (es) 2015-11-10
DOP2002000431A (es) 2003-01-15
CN1551781B (zh) 2013-01-02
AP2003002937A0 (en) 2003-12-31
CA2451626A1 (en) 2003-01-16
CA2451626C (en) 2011-05-31
IS7076A (is) 2003-12-15
YU102203A (sh) 2006-05-25
EA200301323A1 (ru) 2005-06-30
NO20035762L (no) 2004-02-02
HUP0400434A2 (en) 2007-08-28
DK2027873T3 (en) 2015-11-09
PT2027873E (pt) 2015-11-03
USRE44399E1 (en) 2013-07-30
JP2005515162A (ja) 2005-05-26
ATE412426T2 (de) 2008-11-15
HK1134900A1 (en) 2010-05-20
EP2842569A1 (en) 2015-03-04
DK1474067T3 (da) 2008-12-08
AR034678A1 (es) 2004-03-03
AU2002309109B2 (en) 2007-12-13
HK1068250A1 (en) 2005-04-29
HK1207584A1 (en) 2016-02-05
NZ530106A (en) 2007-06-29
WO2003003941A3 (en) 2004-07-29
ZA200309698B (en) 2014-04-30
PL209773B1 (pl) 2011-10-31
HU230246B1 (hu) 2015-11-30
EP1474067A2 (en) 2004-11-10

Similar Documents

Publication Publication Date Title
HK1207584A1 (en) One dose vaccination with mycoplasma hyopneumoniae
HUP0400687A3 (en) Mycoplasma hyopneumoniae bacterin vaccine
HK1111103A1 (zh) 對抗豬肺炎支原體及豬病毒的組合疫苗
AU2002228993A1 (en) Mycoplasma hyopneumoniae bacterin vaccine
PL370359A1 (en) Vaccines
GB0130215D0 (en) Vaccine
GB0407935D0 (en) Vaccine
HUP0301634A3 (en) Temperature-sensitive live vaccine for mycoplasma hyopneumoniae
AU2002335609A8 (en) Multivalent mycoplasma bacterin
SI1546357T1 (sl) Imunogeni polipeptidi mycoplasma hyopneumoniae
PL341797A1 (en) Recombined vaccine against mycoplasma hyopneumoniae
AU2003267992A8 (en) Mycoplasma gallisepticum formulation
GB0105944D0 (en) Anaesthetic Formulation
GB0113552D0 (en) Vaccines
GB0129338D0 (en) Vaccination
GB0130823D0 (en) Vaccine
GB0106589D0 (en) Vaccine
GB0115496D0 (en) Vaccine
GB0124137D0 (en) Vaccine
GB0103867D0 (en) Vaccine